Comparable stake leader
Foresite Capital Fund VI LP
SEC ownership of ALUMIS INC.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001847367.
Disclosed value leader
AyurMaya Capital Management Company, LP
Comparable rows
50/50
Latest evidence
30 Jun 2026
- Public ticker
- ALMS on Nasdaq
- Parsed ownership sources
-
13D/G, 3/4/5, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Foresite Capital Fund VI LP
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Foresite Capital Fund VI LP
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001847367
- Issuer location
- South San Francisco, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of ALUMIS INC. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Foresite Capital Fund VI LP
Disclosed value leader
AyurMaya Capital Manageme...
Comparable rows
50/50
Latest evidence
30 Jun 2026
13D/G
3/4/5
13F
Lead comparable stake: 13%
13D/G row: Foresite Capital Fund VI LP
Showing 1-8 of 50 holder rows.
Quick read
Foresite Capital Fund VI LP leads the comparable SEC ownership view at 13%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Foresite Capital Fund VI LP's linked filing trail.
Comparable ownership
Top 5
Foresite Capital Fund VI LP
13%
AyurMaya Capital Management Compa...
12%
Deep Track Capital, LP
6%
BlackRock, Inc.
5.7%
FMR LLC
5.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Foresite Capital Fund VI LP |
13D/G
3/4/5
James B. Tananbaum · 10%+ Owner
|
13%
|
$422,163,758
15,693,820 shares
|
-$13,341,970 | 01 Apr 2026 |
| AyurMaya Capital Management Company, LP |
13F
13D/G
3/4/5
Company · Director, Other*, 10%+ Owner
|
12%
from 13D/G
|
$426,031,355
15,139,707 shares
|
— | 30 Jun 2026 |
| Deep Track Capital, LP |
13F
13D/G
Company
|
6%
from 13D/G
|
$178,648,422
6,348,558 shares
|
— | 30 Jun 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
5.7%
from 13D/G
|
$231,258,771
8,218,151 shares
|
— | 30 Jun 2026 |
| FMR LLC |
13F
13D/G
Company
|
5.5%
from 13D/G
|
$190,484,444
6,769,170 shares
|
— | 30 Jun 2026 |
| Samsara BioCapital, L.P. |
13D/G
Srinivas Akkaraju
|
5.4%
|
$61,929,972
6,345,219 shares
|
+$11,811,946 | 09 Jan 2026 |
| venBio Global Strategic Fund IV, L.P. |
13D/G
|
4.8%
|
$21,297,292
4,619,803 shares
|
$0 | 30 Jun 2025 |
| Foresite Capital Management V, LLC |
13F
3/4/5
Company · 10%+ Owner
|
0.55%
from 3/4/5
|
$165,941,439
5,896,995 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$50,418,090.
Buys
$50,952,400
Insiders: 4
Sells
$534,311
Insiders: 6
Net
+$50,418,090
Shares: +4,809,085
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 4,829,038
Shares: 19,953
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 19,953 | $0 | $534,311 | -$534,311 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 2,445,520 | 0 | $36,184,297 | $0 | +$36,184,297 |
| 9-12 | 2,383,518 | 0 | $14,768,103 | $0 | +$14,768,103 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 28 reporting-owner rows connected to ALUMIS INC.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
28
Largest Forms 3/4/5 holder
Srinivas Akkaraju
Net 12M change
+$50,418,090
Latest report
03 Aug 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Srinivas Akkaraju | Director | $139,863,445 | +$19,069,487 | +16% | Mixed | 30 Jun 2026 |
| AyurMaya Capital Management Company, LP | Director, Other*, 10%+ Owner | $65,554,931 | Mixed | 21 May 2025 | ||
| David M. Goldstein | Chief Scientific Officer | $6,929,558 | -$68,457 | -0.98% | Mixed | 03 Aug 2026 |
| Foresite Capital Management VI LLC | 10%+ Owner | $6,641,543 | +$10,627,638 | +160% | Mixed | 01 Apr 2026 |
| James B. Tananbaum | Director, 10%+ Owner | $6,641,543 | +$10,627,638 | +160% | Mixed | 01 Apr 2026 |
| Foresite Capital Fund V, L.P. | 10%+ Owner | $6,641,543 | Mixed | 01 Apr 2026 | ||
| Foresite Capital Opportunity Fund V, L.P. | 10%+ Owner | $6,641,543 | Mixed | 01 Apr 2026 | ||
| Foresite Capital Fund VI LP | 10%+ Owner | $6,641,543 | Mixed | 01 Apr 2026 | ||
| Foresite Labs Affiliates 2021, LLC | 10%+ Owner | $6,641,543 | Mixed | 01 Apr 2026 | ||
| Foresite Labs Fund I, L.P. | 10%+ Owner | $6,641,543 | Mixed | 01 Apr 2026 | ||
| Foresite Labs Management I, LLC | 10%+ Owner | $6,641,543 | Mixed | 01 Apr 2026 | ||
| Labs Co-Invest V, LLC | 10%+ Owner | $6,641,543 | Mixed | 01 Apr 2026 | ||
| Foresite Labs, LLC | 10%+ Owner | $6,641,543 | +$10,627,638 | +160% | Mixed | 01 Apr 2026 |
| Foresite Capital Opportunity Management V, LLC | 10%+ Owner | $6,641,543 | Mixed | 01 Apr 2026 | ||
| Foresite Capital Management V, LLC | 10%+ Owner | $6,641,543 | Mixed | 01 Apr 2026 | ||
| Roy C. Hardiman | Chief Business & Strategy Ofcr | $5,658,836 | -$70,988 | -1.2% | Mixed | 03 Aug 2026 |
| Mark Christopher Bradley | Chief Development Officer | $1,843,346 | -$67,824 | -3.5% | Mixed | 03 Aug 2026 |
| Jorn Drappa | Chief Medical Officer | $1,500,242 | -$64,527 | -4.1% | Filing P/S | 03 Aug 2026 |
| John R. Schroer | Chief Financial Officer | $651,813 | -$86,546 | -12% | Filing P/S | 03 Aug 2026 |
| Zhengbin Yao | Director | $596,616 | Mixed | 30 Jun 2026 |
Recent insider transactions for ALUMIS INC.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| John R. Schroer | ALMS | Common Stock | Sale | -11.7% | $86,546 | $26.37 | -3,282 | 24,718 | 03 Aug 2026 | Direct |
| Sanam Pangali | ALMS | Common Stock | Sale | -12.3% | $35,969 | $26.37 | -1,364 | 9,747 | 03 Aug 2026 | Direct |
| Roy C. Hardiman | ALMS | Common Stock | Sale | -1.28% | $70,988 | $26.37 | -2,692 | 207,746 | 03 Aug 2026 | Direct |
| David M. Goldstein | ALMS | Common Stock | Sale | -7.73% | $68,457 | $26.37 | -2,596 | 30,970 | 03 Aug 2026 | Direct |
| Jorn Drappa | ALMS | Common Stock | Sale | -4.12% | $64,527 | $26.37 | -2,447 | 56,892 | 03 Aug 2026 | Direct |
| Mark Christopher Bradley | ALMS | Common Stock | Sale | -5.03% | $67,824 | $26.37 | -2,572 | 48,533 | 03 Aug 2026 | Direct |
| Sanam Pangali | ALMS | Common Stock | Sale | -31% | $140,000 | $28.00 | -5,000 | 11,111 | 06 Jul 2026 | Direct |
| Sanam Pangali | ALMS | Common Stock | Options Exercise | 45% | 5,000 | 16,111 | 06 Jul 2026 | Direct | ||
| Sanam Pangali | ALMS | Stock Option (Right to Buy) | Options Exercise | -12.2% | -5,000 | 36,000 | 06 Jul 2026 | Direct | ||
| Lynn A. Tetrault | ALMS | Common Stock | Award | 3,553 | 3,553 | 30 Jun 2026 | Direct | |||
| Lynn A. Tetrault | ALMS | Stock Option (Right to Buy) | Award | 15,528 | 15,528 | 30 Jun 2026 | Direct | |||
| Zhengbin Yao | ALMS | Common Stock | Award | 15.1% | 3,553 | 27,082 | 30 Jun 2026 | Direct | ||
| Zhengbin Yao | ALMS | Stock Option (Right to Buy) | Award | 15,528 | 15,528 | 30 Jun 2026 | Direct | |||
| Sapna Srivastava | ALMS | Common Stock | Award | 3,553 | 3,553 | 30 Jun 2026 | Direct | |||
| Sapna Srivastava | ALMS | Stock Option (Right to Buy) | Award | 15,528 | 15,528 | 30 Jun 2026 | Direct | |||
| Patrick Machado | ALMS | Common Stock | Award | 3,553 | 3,553 | 30 Jun 2026 | Direct | |||
| Patrick Machado | ALMS | Stock Option (Right to Buy) | Award | 15,528 | 15,528 | 30 Jun 2026 | Direct | |||
| Srinivas Akkaraju | ALMS | Common Stock | Award | 3,553 | 3,553 | 30 Jun 2026 | Direct | |||
| Srinivas Akkaraju | ALMS | Stock Option (Right to Buy) | Award | 15,528 | 15,528 | 30 Jun 2026 | Direct | |||
| Jorn Drappa | ALMS | Common Stock | Options Exercise | 82.6% | 26,852 | 59,339 | 22 May 2026 | Direct | ||
| Jorn Drappa | ALMS | Stock Option (Right to Buy) | Options Exercise | -14.4% | -26,852 | 159,805 | 22 May 2026 | Direct | ||
| Foresite Labs, LLC | ALMS | Common Stock | Other | 1,803,823 | 1,123,337 | 01 Apr 2026 | See Footnote | |||
| Foresite Labs, LLC | ALMS | Common Stock | Other | 1,803,823 | 1,123,337 | 01 Apr 2026 | See Footnote | |||
| Foresite Labs, LLC | ALMS | Common Stock | Other | -100% | -2,299,807 | 0 | 01 Apr 2026 | See Footnote | ||
| Foresite Labs, LLC | ALMS | Common Stock | Other | -100% | -2,299,807 | 0 | 01 Apr 2026 | See Footnote | ||
| Foresite Capital Management VI LLC | ALMS | Common Stock | Other | 1,803,823 | 1,123,337 | 01 Apr 2026 | See Footnote | |||
| Foresite Capital Management VI LLC | ALMS | Common Stock | Other | 1,803,823 | 1,123,337 | 01 Apr 2026 | See Footnote | |||
| Foresite Capital Management VI LLC | ALMS | Common Stock | Other | 1,803,823 | 1,123,337 | 01 Apr 2026 | See Footnote | |||
| Foresite Capital Management VI LLC | ALMS | Common Stock | Other | 1,803,823 | 1,123,337 | 01 Apr 2026 | See Footnote | |||
| Foresite Capital Management VI LLC | ALMS | Common Stock | Other | 1,803,823 | 1,123,337 | 01 Apr 2026 | See Footnote | |||
| Foresite Capital Management VI LLC | ALMS | Common Stock | Other | 1,803,823 | 1,123,337 | 01 Apr 2026 | See Footnote | |||
| Foresite Capital Management VI LLC | ALMS | Common Stock | Other | 1,803,823 | 1,123,337 | 01 Apr 2026 | See Footnote | |||
| Foresite Capital Management VI LLC | ALMS | Common Stock | Other | 1,803,823 | 1,123,337 | 01 Apr 2026 | See Footnote | |||
| Foresite Capital Management VI LLC | ALMS | Common Stock | Other | 1,803,823 | 1,123,337 | 01 Apr 2026 | See Footnote | |||
| Foresite Capital Management VI LLC | ALMS | Common Stock | Other | -100% | -2,299,807 | 0 | 01 Apr 2026 | See Footnote | ||
| Foresite Capital Management VI LLC | ALMS | Common Stock | Other | -100% | -2,299,807 | 0 | 01 Apr 2026 | See Footnote | ||
| Foresite Capital Management VI LLC | ALMS | Common Stock | Other | -100% | -2,299,807 | 0 | 01 Apr 2026 | See Footnote | ||
| Foresite Capital Management VI LLC | ALMS | Common Stock | Other | -100% | -2,299,807 | 0 | 01 Apr 2026 | See Footnote | ||
| Foresite Capital Management VI LLC | ALMS | Common Stock | Other | -100% | -2,299,807 | 0 | 01 Apr 2026 | See Footnote | ||
| Foresite Capital Management VI LLC | ALMS | Common Stock | Other | -100% | -2,299,807 | 0 | 01 Apr 2026 | See Footnote | ||
| Foresite Capital Management VI LLC | ALMS | Common Stock | Other | -100% | -2,299,807 | 0 | 01 Apr 2026 | See Footnote | ||
| Foresite Capital Management VI LLC | ALMS | Common Stock | Other | -100% | -2,299,807 | 0 | 01 Apr 2026 | See Footnote | ||
| Foresite Capital Management VI LLC | ALMS | Common Stock | Other | -100% | -2,299,807 | 0 | 01 Apr 2026 | See Footnote | ||
| James B. Tananbaum | ALMS | Common Stock | Other | 1,803,823 | 1,123,337 | 01 Apr 2026 | See Footnote | |||
| James B. Tananbaum | ALMS | Common Stock | Other | -100% | -2,299,807 | 0 | 01 Apr 2026 | See Footnote | ||
| Sanam Pangali | ALMS | Stock Option (Right to Buy) | Award | 186,200 | 186,200 | 26 Jan 2026 | Direct | |||
| Mark Christopher Bradley | ALMS | Stock Option (Right to Buy) | Award | 190,225 | 190,225 | 26 Jan 2026 | Direct | |||
| Jorn Drappa | ALMS | Stock Option (Right to Buy) | Award | 221,450 | 221,450 | 26 Jan 2026 | Direct | |||
| David M. Goldstein | ALMS | Stock Option (Right to Buy) | Award | 216,675 | 216,675 | 26 Jan 2026 | Direct | |||
| John R. Schroer | ALMS | Stock Option (Right to Buy) | Award | 202,225 | 202,225 | 26 Jan 2026 | Direct |
* marks a reported price that did not pass the local price check.